Company / R&D per Share
Tonix Pharmaceuticals Holding Corp. R&D per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$9.11
FY2025
5-year range
$6.62 / $4141.02
FY2023-FY2025
Trend
-99.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $6.62 to $9.11 over the past 2 years.
Based on SEC 10-K filings.
9.11 in FY2025.
Improved from $6.62 to $9.11 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share decreased 99.8% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.11 | -99.8% |
| FY2024 | $4141.02 | +62456.4% |
| FY2023 | $6.62 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 28, 2026